Nebius Stock: A 571% Sales Jump, a $27 Billion Budget, and a Data Center Slip That Moved the Goalposts
Published on 11/15/2026 at 14:41 | Editorial boerse-global.de
Nebius spent Thursday proving it can grow at a pace few companies in any industry can match. By Friday, the market had decided that wasn't the point.
Shares fell 9.6% after the company disclosed that capacity at an external data center site will not come online as planned, pushing expected revenue into next year. The selloff followed quarterly results and a revised outlook, and it landed hardest on the one question investors now care about most: whether the infrastructure behind Nebius's growth will arrive on schedule.
The Numbers That Started the Slide
Third-quarter 2026 revenue climbed 571% year over year to $980.8 million. For the full year, Nebius now expects sales at the low end of its previous $3.0 billion to $3.4 billion range — a narrowing announced Thursday alongside the results.
The company also raised its capital spending plan for the current year to roughly $27 billion, up from a prior $20 billion to $25 billion target. Additional capacity tied to the delayed third-party site has been pushed into the second quarter of 2027.
Should investors sell immediately? Or is it worth buying Nebius?
That combination — explosive top-line growth, a bigger build-out bill, and a later delivery date — is what turned a strong quarter into a losing session.
Two Analysts, Two Verdicts
Baird cut its price target to $200 from $340 on Friday while keeping an Outperform rating, citing the data center delays and their effect on annual recurring revenue forecasts, including at the Vineland location. D.A. Davidson went further on the valuation front, halving its target to $125 from $250, though it held its Neutral stance.
The gap between the two is the story. Baird slashed its number but stayed constructive; D.A. Davidson paired its cut with a neutral view. Two more research houses trimmed targets on Friday as well, with new levels between $245 and $265, both reaffirming buy recommendations.
For investors, that split argues against reading a lower target as a full retreat from the growth case. It also shows how much weight the execution of the build-out now carries.
What Recovery Would Require
The bull case no longer rests on proving demand. It rests on delivery. If the deferred capacity becomes available inside the announced window, the delay could be reclassified as a timing hit rather than evidence of permanently weaker expansion. Baird's retained Outperform rating fits that reading — but it is not confirmation that the build-out succeeds. The optimistic view remains tied to operational progress, and a credible demonstration of execution would say more than a restatement of ambitious growth goals.
Nebius at a turning point? This analysis reveals what investors need to know now.
The bear case extends past a single late site. Another slip would force investors to question the durability of later revenue assumptions, and the already-narrowed outlook shows that delays do not pass through the business expectations without a mark.
The operative date to watch is the second quarter of 2027. Progress reports on the affected capacity would be the clearest catalyst for how the story gets repriced from here. Until then, the investment case hinges less on the pace of growth already booked than on the reliability of the ground it will be built on.
Ad
Nebius Stock: New Analysis - 15 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
